EMEA-001609-PIP01-14
Key facts
| Active substance |
|
| Therapeutic area |
Vaccines
|
| Decision number |
P/0125/2015
|
| PIP number |
EMEA-001609-PIP01-14
|
| Pharmaceutical form(s) |
Suspension for injection
|
| Condition(s) / indication(s) |
Prevention of acute norovirus gastroenteritis
|
| Route(s) of administration |
Intramuscular use
|
| Contact for public enquiries |
Takeda Vaccines, Inc.
Tel. +1 6174 442147 |
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|